FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
93 letters match. Newest first.
-
DrugsCohere Beauty
FDA cites Cohere Beauty for unvalidated OTC drug manufacturing and inadequate quality oversight at its Santa Fe Springs facility.
Medium -
DrugsFirstCham Co., Ltd.
FDA warns FirstCham over current good manufacturing practice violations and misbranding of Soo'Ae hand sanitizing wipes.
High risk -
DrugsAntaria Pty. Ltd.
FDA warned Antaria Pty. Ltd. about manufacturing quality failures in its active drug ingredient, including poor out-of-specification investigations and testing.
High risk -
DrugsHigley Industries, Inc.
FDA warns Higley Industries over CGMP failures in OTC drug manufacturing, including untested ethanol and glycerin.
High risk -
DrugsThai Nakorn Patana Co., Ltd.
FDA warns Thai Nakorn Patana over manufacturing quality violations, including missing identity and strength testing before release of OTC drugs.
High risk -
DrugsCerci Kozmetik Ve Otel Ekipmanlari Pazarlama Ic Ve Dis Ticaret Limited Sirketi
FDA: Turkish OTC drug maker Cerci shipped to the U.S. without finished-product identity and strength testing.
High risk -
DrugsSeoul Cosmetics Co., Ltd.
FDA warned Seoul Cosmetics, a South Korean drug maker, over poor manufacturing quality and unapproved OTC drugs.
High risk -
DrugsDenison Pharmaceuticals, LLC
Denison Pharmaceuticals was cited for manufacturing quality failures, contamination risks, and unapproved infant/homeopathic drugs.
High risk -
DevicesIntegra LifeSciences Corporation
FDA warned Integra LifeSciences over collagen-based medical devices made in Boston after an inspection found quality-system failures and endotoxin testing problems.
High risk -
DrugsIntas Pharmaceuticals Limited
FDA warned Intas Pharmaceuticals about serious manufacturing-quality violations, including data integrity failures and inaccurate environmental monitoring, at its India drug plant.
High risk -
DrugsSure-Biochem Laboratories, LLC
FDA says contract lab Sure-Biochem missed Burkholderia cepacia in drug samples and cites broad CGMP failures.
High risk -
FoodPop Daddy Popcorn, LLC
FDA warns Pop Daddy Popcorn over insanitary conditions and food safety rule violations for ready-to-eat pretzels.
High risk -
FoodAspire Pharmaceuticals, Inc.
FDA warning letter to Aspire Pharmaceuticals cites dietary supplement and drug CGMP violations, including falsified lab data and missing impurity testing.
High risk -
DrugsDunagin Pharmaceuticals Inc. dba Massco Dental
Dunagin Pharmaceuticals dba Massco Dental made oral drugs with CGMP violations including shared equipment and inadequate component testing.
High risk -
DrugsB & J Group
B & J Group, a Morrisville, PA contract filler of OTC hand sanitizer, was cited by FDA for skipping finished-product and ingredient testing.
High risk -
DrugsSkyless, LLC
FDA cited Skyless, LLC for CGMP failures and for selling three X-PASMO topical analgesic ointments as unapproved and misbranded drugs.
High risk -
DrugsFei Fah Medical Manufacturing Pte. Ltd.
FDA warned Fei Fah Medical Manufacturing over inadequate stability data, unvalidated test methods, and supplier testing failures for over-the-counter drugs.
High risk -
DrugsBuzzagogo, LLC
Buzzagogo's Allergy Bee Gone for Kids nasal swab is an unapproved new drug contaminated with Bacillus bacteria.
High risk -
DrugsDuPont Nutrition USA Inc.
FDA found DuPont released Avicel excipient that failed conductivity limits, citing weak investigations and data integrity lapses.
High risk -
DrugsGreen Wave Analytical, LLC
FDA warned Green Wave Analytical, a contract drug testing lab, over quality violations and its denied inspection access.
High risk -
FoodOregon’s Wild Harvest, Inc.
FDA warned Oregon's Wild Harvest after a September 2021 inspection found dietary supplement manufacturing violations: unproven identity and strength tests and foreign material in ingredients.
High risk -
DrugsGenlabs Corporation
FDA warns Genlabs Corporation of Chino, California, that its OTC hand soaps are adulterated and misbranded after finding serious CGMP failures.
High risk -
DrugsHybrid Pharma, LLC
FDA warned outsourcing facility Hybrid Pharma of Deerfield Beach, Florida, that sterile compounding violations made its drugs adulterated and unapproved.
High risk -
DrugsSpecialty Process Labs LLC
FDA warned Specialty Process Labs about manufacturing quality failures for thyroid USP active ingredient, including unvalidated processes and data control gaps.
High risk -
DrugsFroggy’s Fog LLC
FDA warns Froggy’s Fog that its OTC hand sanitizer was made under inadequate CGMP and mislabeled for alcohol strength.
High risk -
DrugsThe W.S. Badger Company, Inc.
FDA warned W.S. Badger over repeat manufacturing-quality failures in OTC drug products, including sunscreen process, cleaning, test-method, and OOS investigation problems.
High risk -
DrugsGuangzhou Zhongkebaishi Health Industry Co., Ltd.
Guangzhou Zhongkebaishi's Hand Sanitizer Gel, labeled 75% ethanol, tested at 51% and was refused US import.
High risk -
DrugsUltra Seal Corporation
FDA warns Ultra Seal and ULTRAtab over manufacturing quality failures in over-the-counter drug cleaning, testing, and release.
High risk -
DrugsYusef Manufacturing Laboratories, LLC
FDA warned Yusef Manufacturing Laboratories over serious CGMP violations in its OTC drugs and hand sanitizers, including untested ethanol.
High risk -
DrugsAccu Bio-Chem Laboratories
FDA warned Accu Bio-Chem Laboratories, a contract OTC drug-testing lab, over inadequate failing-result investigations, method verification, and data controls.
Medium -
FoodRainfield Marketing Group, Inc.
Rainfield Marketing Group lacked required foreign supplier verification programs for imported mushrooms and spinach after a Listeria finding.
High risk -
DrugsCosmo Bio Co., Ltd.
FDA cited South Korea's Cosmo Bio for CGMP failures and for selling an unapproved, misbranded acne drug serum in the U.S.
High risk -
DrugsChameleon Beverage Co. Inc. dba Chameleon Sanitizer Corporation
FDA warned Chameleon Sanitizer Corporation that its hand sanitizer was made under insanitary conditions and violated manufacturing and misbranding rules.
High risk -
DrugsBionateo Sp. z.o.o.
Bionateo, a Polish drugmaker, shipped hand sanitizer contaminated with methanol and isopropanol that FDA refused at the U.S. border.
High risk -
DrugsArdil Comercial S.R.L.
FDA found Ardil Comercial's Limar hand sanitizer contained less isopropyl alcohol and undeclared ethanol and was packaged like a water bottle.
High risk -
BiologicsUtah Cord Bank LLC dba Utah Cell Bank
Utah Cell Bank made unapproved injectable stem cell products and fell short on sterility and manufacturing controls, FDA found.
High risk -
DrugsBBC Group Limited
FDA cites BBC Group Limited for data integrity, lab, equipment failures and unapproved, misbranded hand sanitizers.
High risk -
DrugsDelta Kozmetik Sanayi Ve Ticaret-Selim Yesil
FDA found Delta Kozmetik's hand sanitizer labeled with higher ethanol was only 59% ethanol and refused import.
High risk -
DrugsAlbek de Mexico S.A. de C.V.
FDA found Albek de Mexico hand sanitizer contained methanol instead of labeled ethanol and was adulterated, unapproved, and misbranded.
High risk -
DrugsInovaker Lab S.A. de C.V.
Inovaker Lab's Hand+ sanitizer labeled 75% ethanol contained 0% ethanol and was refused entry to the U.S.
High risk -
DrugsAbsara Cosmetics S.A.P.I DE C.V.
Absara Cosmetics' hand sanitizer labeled 70% ethanol tested at 58%, leading to CGMP citations.
High risk -
DrugsShangRao Chunyu Technology Co., Ltd.
FDA warns ShangRao Chunyu Technology that its Instant Hand Sanitizer labeled 75% ethanol tested at 58% and is adulterated.
High risk -
DrugsSimex Logistics S.A. de C.V.
Mexican drugmaker Simex Logistics shipped hand sanitizer labeled 70% alcohol that tested at 51%, FDA says.
High risk